Navigation Links
Pixantrone Shows Activity in a Preclinical Study of Experimental Autoimmune Myasthenia Gravis (EAMG)
Date:2/11/2008

ve clinically in a number of tumor types. However, they are usually associated with cumulative heart damage that prevents them from being used in a large proportion of patients. Pixantrone has been designed to reduce the potential for these severe cardiotoxicities, as well as to potentially increase activity and permit simplified administration compared to the currently marketed anthracyclines.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit http://www.cticseattle.com.

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results. Specifically, the risks and uncertainties that could affect the development of pixantrone include risks associated with preclinical and clinical developments in the biopharmaceutical industry in general and with pixantrone in particular including, without limitation, the potential failure of pixantrone to be tested in or have comparable results in human clinical trials of myasthenia gravis, determinations by regulatory, patent and administrative governmental authorities, competitive factors, technological developments, costs of developing, producing and selling pixantrone, and the risk factors listed or described from time to time in the Company's filings with the Securities and Exchange Commission including, without limitation, the Company's most recent filings on Forms 10-K, 8-K, and 10-Q. Except as may be required by law, CTI does not intend to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.

Media Contact:

Dan Eramian

T: 206.272.4343

C: 206.854.12
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
2. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
3. Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells
4. JAK2 Inhibitor Shows Potent Activity in Cells From MPD Patients
5. Newly Approved HIV Drug Shows Great Promise
6. Kaiser Permanente - Group Health Study Shows Depression Worsens HIV Treatment
7. Research Shows Decas Sweetened Dried Cranberries Pack Twice the Proanthocyanidin Punch as Cranberry Juice Cocktail
8. New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol
9. CSL Behring Study in Animal Models Shows Feasibility of Developing a Half-Life Extended Recombinant FVIIa that Retains Biologic Activity
10. Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)
11. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 Today, Rhodes Pharmaceuticals ... system stimulant indicated for the treatment of Attention-Deficit/Hyperactivity ... Summer 2015. The announcement comes ... from the U.S. Food and Drug Administration (FDA). ... formulation of methylphenidate capsule with an onset of ...
(Date:5/22/2015)... LONDON , May 22, 2015 ... early phase clinical research unit with a worldwide ... respected for its frequent publications in peer reviewed ... and European stakeholders and regulators in discussions about ... results.      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , ...
(Date:5/22/2015)... 22, 2015  China Nepstar Chain Drugstore Ltd. (NYSE: ... drugstore chain in China based ... the resignation of Mr. Fuxiang Zhang as ... immediately. Ms. Rebecca Yingnan Zhang has been ... of directors, effective immediately. Meanwhile, Ms. Zhang resigned from ...
Breaking Medicine Technology:Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3
... July 24 Terumo Cardiovascular Systems (Terumo CVS) announced that ... Anaconda(TM) AAA (Abdominal Aortic Aneurysm) Stent Graft System in the ... subsidiary Vascutek Ltd. The first U.S. implant was ... principal investigator, Julio Rodriguez-Lopez, M.D. , ...
... SAN MATEO, Calif., July 24 NeurogesX, ... preliminary results of a short-term clinical study (Study C123) ... pretreatment with an FDA-approved topical anesthetic. As part of ... Food and Drug Administration (FDA) requested the study to ...
Cached Medicine Technology:Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda(TM) AAA Stent Graft System 2NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study 2NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study 3NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study 4
(Date:5/23/2015)... 23, 2015 On May 13, Nithyananda ... a youngster's yogic power learned through meditation and initiation ... in Bangalore, India. , Yogamaatha, a nine-year-old girl from ... high profile professionals attending the 2015 Business Advocacy Summit ... -- blindfolded. , In a demonstration that lasted ...
(Date:5/23/2015)... Manufacturers are now required to produce water heaters with ... in the field agree that the regulation is aimed at ... is what miles per gallon is to your car. The ... minimum HSPF score has been raised to 8.2, technology has ... of 12. Indeed, the regulation was welcomed by environmentalist, and ...
(Date:5/22/2015)... The world is at a "hinge ... to create new opportunities for leadership in health ... WesternU's 34th annual Commencement Exercises said Wednesday, May ... former San Francisco mayor and likely 2018 gubernatorial ... ceremony for WesternU's colleges of Allied Health Professions ...
(Date:5/22/2015)... York (PRWEB) May 22, 2015 ... filed on behalf of individuals who allegedly experienced ... its use continue to move forward in the ... to a Pretrial Order dated May 4, 2015, ... of documents and electronically stored information. Among other ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 “It’s ... MS/CCC, SLP, RAC-CT, CHHRP-QT, Vice President of Clinical ... very important ‘language’ that impacts how care is ... leader in long term care reimbursement, operations and ... programs and talent management, launches a new series ...
Breaking Medicine News(10 mins):Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:Parker & Sons Welcomes the Department of Energy’s Water Heater Regulation 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 4Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 3
... ... detecting lead levels in the body, , ... San Diego, CA (Vocus) July 6, 2009 -- Until now, determining a person’s ... ,However, that has changed thanks to LeadConfirm Professional, a new saliva-based lead test ...
... and undernutrition occurs not in conflicts and natural disasters ... article published this week in open access journal ... of year when the previous year,s harvest stocks have ... and is often under recognized. Bapu Vaitla (Tufts ...
... newly discovered mechanism controls whether muscle cells in blood ... disease, according to an article published online today in ... led by the Gladstone Institute of Cardiovascular Disease (GICD) ... Cardiovascular Research Institute at the University of Rochester School ...
... health care may explain results, study says , FRIDAY, ... United States scored better than their counterparts in England ... differences in levels of depression and education and the ... heart disease, a new study suggests. , The test ...
... ... October. , ... July 3, 2009 -- Companies and organisations throughout the UK are being urged to celebrate ... 5-11 October., , ,Employers in all sectors, from the largest business to the corner shop ...
... lead to treatments, , FRIDAY, July 3 (HealthDay News) ... that may drive the rapid spread of relapsed lung cancer. ... But most cases are not detected until the disease is ... remission, the disease often springs back more virulent than ever, ...
Cached Medicine News:Health News:LeadConfirm Professional Now Available at Overstock.com--The First Oral Based Lead Test Makes Getting the Lead Out Easier 2Health News:LeadConfirm Professional Now Available at Overstock.com--The First Oral Based Lead Test Makes Getting the Lead Out Easier 3Health News:LeadConfirm Professional Now Available at Overstock.com--The First Oral Based Lead Test Makes Getting the Lead Out Easier 4Health News:Study in Nature: MicroRNAs hold promise for treating diseases in blood vessels 2Health News:Study in Nature: MicroRNAs hold promise for treating diseases in blood vessels 3Health News:Study in Nature: MicroRNAs hold promise for treating diseases in blood vessels 4Health News:On Memory, Older Americans Outsmart the English 2Health News:Businesses Urged to Sign Up and Celebrate Customer Service 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 3
... Used to connect ... an infusion pump, and ... catheter in order to ... use with Laborie Medical ...
Used for suprapubic monitoring of bladder pressures. Suprapubic urodynamic studies avoid the effects of urethral catheterization and eliminate the need for a double bladder puncture. Supplied sterile...
... Cardiac Panel is a fluorescence ... quantitative determination of CK-MB, myoglobin ... acid (EDTA) whole blood and ... used as an aid in ...
... When your patients present with AMI ... essence, RAMP offers a rapid, reliable ... needs. Utilizing unique assay enhancement techniques, ... flow test cartridges, RAMP delivers highly ...
Medicine Products: